| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERON PHARMA | 1,480,060 | 39,059,000 | 73.52% | ||
| 2 | ALIMERA SCIENCES INC | 3,148,355 | 5,510,000 | 10.37% | ||
| 3 | PULMATRIX INC | 1,591,862 | 4,664,000 | 8.78% | ||
| 4 | CERULEAN PHARMA INC | 1,437,441 | 3,895,000 | 7.33% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017096, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
